ENSPRYNG Trademark

Trademark Overview

On Thursday, September 5, 2013, a trademark application was filed for ENSPRYNG with the United States Patent and Trademark Office. The USPTO has given the ENSPRYNG trademark a serial number of 86056706. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 6, 2017. This trademark is owned by GENENTECH, INC.. The ENSPRYNG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical oncology and neuroendocrine hormone preparations
enspryng

General Information

Serial Number86056706
Word MarkENSPRYNG
Filing DateThursday, September 5, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements

Goods and ServicesPharmaceutical oncology and neuroendocrine hormone preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Monday, March 6, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 6, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, July 15, 2016EXTENSION 5 GRANTED
Thursday, June 30, 2016EXTENSION 5 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Tuesday, February 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Saturday, February 13, 2016EXTENSION 4 GRANTED
Tuesday, January 26, 2016EXTENSION 4 FILED
Tuesday, January 26, 2016TEAS EXTENSION RECEIVED
Wednesday, August 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, August 4, 2015EXTENSION 3 GRANTED
Monday, July 27, 2015EXTENSION 3 FILED
Monday, July 27, 2015TEAS EXTENSION RECEIVED
Tuesday, March 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, March 16, 2015EXTENSION 2 GRANTED
Tuesday, January 27, 2015EXTENSION 2 FILED
Thursday, March 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 27, 2015TEAS EXTENSION RECEIVED
Wednesday, July 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, July 21, 2014EXTENSION 1 GRANTED
Monday, July 21, 2014EXTENSION 1 FILED
Monday, July 21, 2014TEAS EXTENSION RECEIVED
Tuesday, January 28, 2014NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTICE OF PUBLICATION
Monday, October 21, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 18, 2013ASSIGNED TO EXAMINER
Friday, September 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 9, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

enspryng preparations hormone neuroendocrine oncology pharmaceutical